ArticleJournal of microbiology and biotechnology2026
Mechanism of Taohong Siwu Decoction in Alleviating PD-Related Cellular Damage based on the MAPK Signaling Pathway.
Article in Journal of microbiology and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aimed to investigate the effects of Taohong Siwu Decoction (THSWD) on apoptosis, viability, and oxidative stress status in a 6-hydroxydopamine (6-OHDA)-induced SH-SY5Y cell injury model, and to analyze the potential involvement of stress-related MAPK (p38/JNK) signaling, specifically p38 and JNK, in its cytoprotective effects. A Parkinson's disease (PD)-related neurotoxic cell injury model was established by exposing SH-SY5Y cells with 6-OHDA. After administering different doses of THSWD, the mRNA expression levels of apoptosis-related genes were quantified by quantitative real-time PCR, apoptotic cell proportions were assessed by flow cytometry, and cell viability was evaluated using the CCK-8 assay. In parallel, intracellular oxidative stress indicators, including ROS, MDA, and antioxidant defense indicators, including SOD, CAT, and GSH, were measured. A drug-component-target-disease network was constructed using network pharmacology methods, followed by protein-protein interaction analysis and Gene Ontology and KEGG pathway enrichment analyses to identify potential signaling pathways. Western blot analysis was performed to assess the phosphorylation levels of p38 and JNK proteins, and mechanistic validation was further conducted using the p38 inhibitor BIRB796. Under 6-OHDA-induced SH-SY5Y cell injury conditions, THSWD treatment significantly downregulated the mRNA expression of
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.